Cargando…
Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes
Studies have demonstrated that total osteocalcin (TOC) is associated with metabolic syndrome (MetS) and therefore might influence the risk of cardiovascular disease in humans. Undercarboxylated osteocalcin (uOC) regulates insulin secretion and sensitivity in mice, but its relation to MetS in humans...
Autores principales: | Alfadda, Assim A., Masood, Afshan, Shaik, Shaffi Ahamed, Dekhil, Hafedh, Goran, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638647/ https://www.ncbi.nlm.nih.gov/pubmed/23653641 http://dx.doi.org/10.1155/2013/197519 |
Ejemplares similares
-
Effect of Weight Loss on Serum Osteocalcin and Its Association with Serum Adipokines
por: Albadah, Mohammed S., et al.
Publicado: (2015) -
Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal Women
por: Atalay, Sacide, et al.
Publicado: (2012) -
Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients
por: Riquelme-Gallego, Blanca, et al.
Publicado: (2020) -
Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes
por: Razny, Urszula, et al.
Publicado: (2016) -
Undercarboxylated osteocalcin correlates with insulin secretion in Japanese individuals with diabetes
por: Funakoshi, Shogo, et al.
Publicado: (2020)